Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

35th Anniversary Special: New Models in Contract Services

July 2, 2012

Pharmaceutical Technology

Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.

Q&A with Thomas E. D'Ambra, AMRI

July 2, 2012
Pharmaceutical Technology

A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.

Reflecting on 35 Years of Procurement Transformation

July 2, 2012

Pharmaceutical Technology

The past three decades have driven a purchasing evolution to a procurement revolution.

A Look into the Future of Pharmaceutical Outsourcing: Perspectives from Jim Miller, president of PharmSource

July 2, 2012

Pharmaceutical Technology

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.

Future Innovation

July 2, 2012
Pharmaceutical Technology

Presidents of leading associations offer views on the industry's future.

Pharmaceutical Technology: 35 Years and Going Strong

July 2, 2012

Pharmaceutical Technology

Taking time to appreciate the industry's greatest achievements will inspire growth ahead.

Biomanufacturing Innovation

June 2, 2012

Pharmaceutical Technology

Industry wants more innovation, but can suppliers meet customer needs?

New Packaging Technologies Displayed at INTERPHEX

June 2, 2012

Pharmaceutical Technology

Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.

CROs Urge for Modernization of Clinical Trials

May 2, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Click here